Case Study Of Pfizer's Merger

919 Words4 Pages

Background of the deal
On February 5, 2015, Pfizer Inc, Hospira Inc., Hospira and Perkins Holding Company (a wholly owned subsidiary of Pfizer) entered into an agreement and Plan of Merger. As per the agreement, Perkings would merge with and into Hospira, with Hospira surviving as a wholly-owned subsidiary of Pfizer.

As per the agreement, each share of Hospira’s common stock (par value $0.01 per share) which was issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time” is nothing but the date and time on which the Merger becomes effective) will be converted into the right to receive $90.00 in cash.
Consummation of the Merger was subject to customary conditions, including:
(i) approval of the holders of a majority of the outstanding shares of Hospira …show more content…

Hospira has agreed to various covenants and agreements, including among other things: (i) to conduct its business in the ordinary course of business during the period between the execution of the Merger Agreement and the closing of the Merger and not to solicit alternative transactions to the Merger.
(ii) Pfizer has agreed to various covenants and agreements, including among other things to take actions that may be required in order to obtain antitrust approval of the Merger.

Motivation for the

Open Document